v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Total revenues $ 12,833 $ 9,277 $ 37,885 $ 43,582
Costs and operating expenses:        
Cost of product revenue 4,317 2,249 12,634 9,947
Research and development 11,505 13,662 34,164 47,651
Selling, general and administrative 13,568 12,302 42,100 41,066
Restructuring charges 0 3,140 0 3,284
Asset impairment and other charges 0 9,984 165 9,984
Total costs and operating expenses 29,390 41,337 89,063 111,932
Loss from operations (16,557) (32,060) (51,178) (68,350)
Interest income 849 1,056 2,730 3,266
Interest and other expense, net (4,922) (3,895) (6,421) (3,930)
Loss before income taxes (20,630) (34,899) (54,869) (69,014)
Provision for income taxes 10 9 31 34
Net loss $ (20,640) $ (34,908) $ (54,900) $ (69,048)
Net loss per share, basic (in dollars per share) $ (0.29) $ (0.50) $ (0.78) $ (1.02)
Net loss per share, diluted (in dollars per share) $ (0.29) $ (0.50) $ (0.78) $ (1.02)
Weighted average common stock shares used in computing net loss per share, basic (in shares) 72,032 69,466 70,759 67,670
Weighted average common stock shares used in computing net loss per share, diluted (in shares) 72,032 69,466 70,759 67,670
Product revenue        
Revenues:        
Total revenues $ 11,158 $ 5,395 $ 26,968 $ 24,807
Research and development revenue        
Revenues:        
Total revenues $ 1,675 $ 3,882 $ 10,917 $ 18,775

Source